Evénements

Zone géographique

Latest outcomes from ex vivo and in vivo studies with Labrasol® ALF and Labrafac™ MC60, intestinal permeation enhancers

7 & 9 March 2023 - on line -

Join us for our webinar, in which Dr. Fiona McCartney shares her latest ex vivo and in vivo results from a Gattefossé sponsored study, at University College of Dublin, that assessed the efficacy of Labrasol® ALF and Labrafac™ MC60 as transient intestinal permeation enhancers.

CPhI – India 2022

29 November - 1 December 2022 - India Expo Centre, Greater Noida, Delhi NCR - 6 M02

CPHI Worldwide

November 1-3, 2022 - Frankfurt, Germany - Booth #80C100

This year again, Gattefossé will be present at CPHI in Frankfurt, Germany, from November 1st to 3rd (80C100 - Hall 8.0).
This year, short "Fast and Curious Facts series" presentations will be organized each day to learn key facts on 9 dedicated topics.

AAPS PHARMSCI 360

October 17-19 - Boston - Booth #216

Meet our Gattefossé team of experts from 17th to 19th October at American Association of Pharmaceutical Scientists (AAPS) in Boston at Booth #216 to discover our latest innovations.

Controlled Release Society 2022

July 11-15, 2022 - Montreal Congress Center, Montreal, Canada - Booth 310

The Gattefossé pharma team will be present at the CRS annual meeting. The conference theme this year is “Advanced Delivery Science”, which reflects our focus on cutting-edge research and innovation across our strong discipline that will keep you up-to-date with new science and inspire new ideas.

Introduction to oral BAE using lipid excipients Part III: Step-by-step development of successful lipid-based formulations

July 7, 2022 - 8:30 am CET - Online -

Join us to the third part of our webinar series "Introduction to oral bioavailability enhancement using lipid excipients". This webinar series will give junior formulators key information to understand how LBF address oral bioavailability issues.
In this third webinar, the methodology to develop optimized lipid-based formulations will be explained.